[Update on the use of radiopharmaceuticals for positron emission tomography imaging of prostate cancer].

  • J. R. Garcia
  • Published 2013 in
    Revista espanola de medicina nuclear e imagen…

Abstract

Adenocarcinoma of the prostate is the most frequent neoplasm in men, with 50% of males over the age of 70 years presenting this type of cancer. In addition, it is the second cause of oncological death.1 The diagnosis of prostate cancer is well established, being based on the determination of the prostate-specific antigen (PSA), rectal tact, transrectal… (More)
DOI: 10.1016/j.remn.2013.01.003

7 Figures and Tables

Topics

  • Presentations referencing similar topics